SR17: Resolution Text

LRB-5046/1

DAK:kmg:pg

2001 - 2002 LEGISLATURE

2001 Senate RESOLUTION 17

March 11, 2002 - Introduced by Senator Grobschmidt. Referred to Committee on Senate Organization.

SR17,1,1 Relating to: proclaiming Prostate Cancer Awareness Month.

SR17,1,3 Whereas, prostate cancer is the most commonly diagnosed form of nonskin cancer and the 2nd-leading cause of cancer-related death among men; and

SR17,1,6 Whereas, the American Cancer Society estimates that 30,200 men in the United States will die of prostate cancer in 2002, with an estimated 4,000 new cases and 600 deaths in Wisconsin in 2002; and

SR17,1,8 Whereas, nationally the number of deaths from prostate cancer has more than doubled over the past 30 years; and

SR17,1,10 Whereas, about 25% of prostate cancer occurs in men under the age of 65, during their prime years at work; and

SR17,1,12 Whereas, at any age, deaths due to prostate cancer devastate families, through loss of income, partnership, and support; and

SR17,1,14 Whereas, prostate cancer leaves too many parents, women, children, and friends without a man whom they love; and

SR17,2,3 Whereas, prostate cancer has accounted, on average, for 15% of the nation's cancer burden and 15% of male cancer deaths, yet it has received, on average, only about 5% of the funds that this nation commits to cancer research; and

SR17,2,6 Whereas, research suggests that men could reduce their risk of prostate cancer mortality if they would follow recommended prostate cancer screening guidelines, including examination by a health care provider; and

SR17,2,8 Whereas, increased awareness and use of early detection practices by men are essential to controlling prostate cancer; now, therefore, be it

SR17,2,13 Resolved by the senate, That: the members of the Wisconsin senate hereby proclaim the month of September as "Prostate Cancer Awareness Month" in the state of Wisconsin and urge all men to become aware of their own risks of prostate cancer, talk to their health care providers about prostate cancer, and, whenever appropriate, be screened for the disease.

SR17,2,14 (End)